These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10390772)

  • 21. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
    Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
    Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on topiramate in epilepsy.
    Lyseng-Williamson KA; Yang LP
    CNS Drugs; 2008; 22(2):171-4. PubMed ID: 18193927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and tolerability of long term topiramate in drug resistant epilepsy in adults].
    Ribacoba Montero R; Salas Puig X
    Rev Neurol; 2002 Jan 16-31; 34(2):101-5. PubMed ID: 11988901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up.
    Kim JM; Kwon S; Seo HE; Choe BH; Cho MH; Park SP
    J Korean Med Sci; 2009 Dec; 24(6):1078-82. PubMed ID: 19949663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate as a new antiepileptic drug in epileptic children in Iran.
    Fallah R
    Indian J Pediatr; 2006 Dec; 73(12):1073-5. PubMed ID: 17202632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate in childhood epileptic encephalopathy with continuous spike-waves during sleep: A retrospective study of 21 cases.
    Vrielynck P; Marique P; Ghariani S; Lienard F; de Borchgrave V; van Rijckevorsel K; Bonnier C
    Eur J Paediatr Neurol; 2017 Mar; 21(2):305-311. PubMed ID: 27641809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate effects on plasma serotonin levels in children with epilepsy.
    Grosso S; Blardi P; Battaglini M; Franzoni E; De Lalla A; Mostardini R; Balestri P
    Epilepsy Res; 2008 Oct; 81(2-3):148-54. PubMed ID: 18603411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experiences with topiramate in children with intractable epilepsy.
    Uldall P; Buchholt JM
    Eur J Paediatr Neurol; 1999; 3(3):105-11. PubMed ID: 10461565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
    Al Ajlouni S; Shorman A; Daoud AS
    Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Course of drug-resistant childhood epilepsy treated with topiramate].
    Prats Viñas JM; Garaizar Axpe C; Martínez González MJ
    Rev Neurol; 2001 Mar 1-15; 32(5):405-8. PubMed ID: 11346818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience in combined topiramate therapy of drug-resistant epilepsy].
    Karlov VA; Vlasov PN; Freĭdkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):21-6. PubMed ID: 12938650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate in the treatment of myoclonic-astatic epilepsy in children: a retrospective hospital audit.
    Jayawant S; Libretto SE
    J Postgrad Med; 2003; 49(3):202-5; discussion 205-6. PubMed ID: 14597780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
    Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
    Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of body weight and galanin in epileptic children treated with topiramate].
    Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using topiramate in patients with epilepsy: practical aspects.
    Sander JW
    Can J Neurol Sci; 1998 Aug; 25(3):S16-8. PubMed ID: 9706736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.